Vibramedica - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 33,584 | 58,324 | 81,816 | 85,211 | 165,216 | 150,052 | 193,145 | 180,005 |
| Profit before tax | -26,319 | -13,400 | 7,396 | -27,994 | 1,920 | 2,127 | 885 | -24,246 |
| Net profit | -26,319 | -13,400 | 7,034 | -28,093 | 1,288 | 1,797 | 593 | -24,246 |
| Equity | -23,898 | -36,722 | -29,689 | -57,781 | -31,494 | -29,697 | -29,103 | -53,350 |
| Liabilities | 95,563 | 109,969 | 119,256 | 148,044 | 97,282 | 88,086 | 87,530 | 100,566 |
| Non-current assets | 66,149 | 60,109 | 66,561 | 81,123 | 58,910 | 46,495 | 39,409 | 36,006 |
| Current assets | 5,516 | 13,138 | 23,006 | 9,107 | 6,459 | 11,697 | 19,011 | 11,175 |
| Total assets | 71,665 | 73,247 | 89,567 | 90,230 | 65,369 | 58,192 | 58,420 | 47,181 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 24,571 | 30,777 | 25,716 |
| Social insurance contributions | - | - | - | - | - | 15,879 | 22,431 | 26,816 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +73.7% | +40.3% | +4.1% | +93.9% | -9.2% | +28.7% | -6.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -36.7% | -18.3% | 7.9% | -31.1% | 2.0% | 3.1% | 1.0% | -51.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -78.4% | -23.0% | 8.6% | -33.0% | 0.8% | 1.2% | 0.3% | -13.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -78.4% | -23.0% | 9.0% | -32.9% | 1.2% | 1.4% | 0.5% | -13.5% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 7,327 | 8,641 | 10,557 | 6,909 | 13,579 | 12,680 | 13,021 | 12,559 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vibramedica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-10-23 | 2025-11-16 | 0.64 |
| 2024-01-23 | 2024-02-14 | 0.17 |
| 2023-11-16 | 2023-12-14 | 93.91 |
| 2023-07-28 | 2023-08-16 | 0.42 |
| 2023-07-24 | 2023-07-25 | 0.43 |
| 2023-05-02 | 2023-05-14 | 0.37 |
| 2023-04-25 | 2023-04-28 | 0.37 |
| 2023-02-06 | 2023-02-14 | 0.59 |
| 2023-01-20 | 2023-02-03 | 0.59 |
| 2022-10-28 | 2022-11-16 | 0.70 |
| 2022-09-16 | 2022-09-18 | 579.54 |
| 2022-07-25 | 2022-08-10 | 0.28 |
| 2022-04-19 | 2022-04-19 | 10.93 |
Vibramedica - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-08-14 | 2026-08-17 | 641.26 |
| 2026-06-01 | 2026-06-05 | 0.19 |
| 2026-05-19 | 2026-05-19 | 482.72 |
| 2026-05-17 | 2026-05-18 | 479.12 |
| 2026-04-14 | 2026-04-15 | 452.85 |
| 2026-02-18 | 2026-02-21 | 4.98 |
| 2026-02-14 | 2026-02-17 | 390.25 |
| 2026-01-29 | 2026-01-29 | 0.13 |
| 2025-11-18 | 2025-11-18 | 147.8 |
| 2025-11-14 | 2025-11-17 | 145.92 |
| 2025-09-30 | 2025-09-30 | 0.44 |
| 2025-04-14 | 2025-04-14 | 114.0 |
| 2024-10-10 | 2024-10-13 | 1.76 |
| 2024-10-09 | 2024-10-09 | 762.03 |
| 2024-10-01 | 2024-10-08 | 760.27 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vibramedica, UAB (code 304731354) is a Private Limited Liability Company operating in other human health activities n.e.c. In 2025, the company generated revenue of €180.0K, down 6.8% year on year, although still 20.0% above 2023. Profitability weakened sharply: after net profit of €1.8K in 2023 and €593 in 2024, the company posted a net loss of €24.2K in 2025, with a profit margin of -13.5%. The balance sheet also deteriorated over the year. Total assets declined to €47.2K from €58.4K in 2024, while liabilities increased to €100.6K and equity deepened to -€53.4K. Long-term assets were €36.0K and short-term assets €11.2K at year-end 2025. Asset turnover remained high at 3.82x, indicating relatively strong revenue generation against the asset base. Revenue per employee was €12.9K, and profit per employee was negative at -€1.7K. Overall, 2025 marked a clear reversal from the small profits of the prior two years.